Irinotecan-induced mucositis encompasses changes in intestinal and colonic cell kinetics and this is associated with altered extracellular matrix component expression

被引:0
|
作者
Al-Dasooqi, N. [1 ,2 ]
Bowen, J. [1 ,2 ]
Gibson, R. [2 ,3 ]
Logan, R. [4 ,5 ]
Stringer, A. [2 ,3 ]
Keefe, D. [1 ,2 ,6 ]
机构
[1] Univ Adelaide, Dept Med, Eastwood, SA, Australia
[2] Royal Adelaide Hosp, Dept Med Oncol, Eastwood, SA, Australia
[3] Univ Adelaide, Discipline Anat Sci, Eastwood, SA, Australia
[4] SA Pathol, Div Surg Pathol, Eastwood, SA, Australia
[5] Fac Hlth Sci, Sch Dent, Eastwood, SA, Australia
[6] Canc Council S Australia, Eastwood, SA, Australia
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:A2 / A2
页数:1
相关论文
共 15 条
  • [1] Irinotecan-induced alterations in intestinal cell kinetics and extracellular matrix component expression in the dark agouti rat
    Al-Dasooqi, Noor
    Bowen, Joanne M.
    Gibson, Rachel J.
    Logan, Richard M.
    Stringer, Andrea M.
    Keefe, Dorothy M.
    INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 2011, 92 (05) : 357 - 365
  • [2] Irinotecan-induced mucositis is associated with changes in intestinal mucins
    Andrea M. Stringer
    Rachel J. Gibson
    Richard M. Logan
    Joanne M. Bowen
    Ann S. J. Yeoh
    Jessica Laurence
    Dorothy M. K. Keefe
    Cancer Chemotherapy and Pharmacology, 2009, 64 : 123 - 132
  • [3] Irinotecan-induced mucositis is associated with changes in intestinal mucins
    Stringer, Andrea M.
    Gibson, Rachel J.
    Logan, Richard M.
    Bowen, Joanne M.
    Yeoh, Ann S. J.
    Laurence, Jessica
    Keefe, Dorothy M. K.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (01) : 123 - 132
  • [4] Matrix metalloproteinases and their inhibitors are altered in a time-course model of irinotecan-induced mucositis
    Al-Dasooqi, N.
    Gibson, R.
    Bowen, J.
    Logan, R.
    Stringer, A.
    Keefe, D.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 : A2 - A2
  • [5] INFLIXIMAB ATTENUATES THE INFLAMMATORY COMPONENT OF IRINOTECAN-INDUCED INTESTINAL MUCOSITIS WITHOUT AFFECTING DIARRHEA
    Figueiredo, A. A.
    Lima-Junior, R. C.
    Leite, C. A. V. G.
    Wong, D. V. T.
    Pereira, S. T. A.
    Aragao, K. S.
    Bem, A. X. C.
    Oria, R. B.
    Magalhaes, P. J. C.
    Souza, M. H. L. P.
    Ribeiro, R. A.
    INFLAMMATION RESEARCH, 2011, 60 : 194 - 194
  • [6] Cell adhesion molecules are altered during irinotecan-induced mucositis: a qualitative histopathological study
    Al-Dasooqi, Noor
    Bowen, Joanne
    Bennett, Colin
    Finnie, John
    Keefe, Dorothy
    Gibson, Rachel
    SUPPORTIVE CARE IN CANCER, 2017, 25 (02) : 391 - 398
  • [7] Cell adhesion molecules are altered during irinotecan-induced mucositis: a qualitative histopathological study
    Noor Al-Dasooqi
    Joanne Bowen
    Colin Bennett
    John Finnie
    Dorothy Keefe
    Rachel Gibson
    Supportive Care in Cancer, 2017, 25 : 391 - 398
  • [8] Irinotecan-Induced Mucositis Is Associated with Goblet Cell Dysregulation and Neural Cell Damage in a Tumour Bearing DA Rat Model
    Thorpe, Daniel
    Butler, Ross
    Sultani, Masooma
    Vanhoecke, Barbara
    Stringer, Andrea
    PATHOLOGY & ONCOLOGY RESEARCH, 2020, 26 (02) : 955 - 965
  • [9] In vitro and in vivo irinotecan-induced changes in expression profiles of cell cycle and apoptosis-associated genes in acute myeloid leukemia cells
    Minderman, H
    Conroy, JM
    O'Loughlin, KL
    McQuaid, D
    Quinn, P
    Li, S
    Pendyala, L
    Nowak, NJ
    Baer, MR
    MOLECULAR CANCER THERAPEUTICS, 2005, 4 (06) : 885 - 900
  • [10] Knockdown of TRIM9 attenuates irinotecan-induced intestinal mucositis in IEC-6 cells by regulating DUSP6 expression via the P38 pathway
    Zhao, Wenjun
    Wang, Qingming
    MOLECULAR MEDICINE REPORTS, 2021, 24 (06)